These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7636859)

  • 1. Effect of lipophilicity at N-1 on activity of fluoroquinolones against mycobacteria.
    Renau TE; Sanchez JP; Shapiro MA; Dever JA; Gracheck SJ; Domagala JM
    J Med Chem; 1995 Jul; 38(15):2974-7. PubMed ID: 7636859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7.
    Renau TE; Sanchez JP; Gage JW; Dever JA; Shapiro MA; Gracheck SJ; Domagala JM
    J Med Chem; 1996 Feb; 39(3):729-35. PubMed ID: 8576916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
    Casal M; Gutierrez J; Ruiz P; Moreno G
    Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position.
    Renau TE; Gage JW; Dever JA; Roland GE; Joannides ET; Shapiro MA; Sanchez JP; Gracheck SJ; Domagala JM; Jacobs MR; Reynolds RC
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2363-8. PubMed ID: 8891145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinolone antibacterials: preparation and activity of bridged bicyclic analogues of the C7-piperazine.
    Kiely JS; Hutt MP; Culbertson TP; Bucsh RA; Worth DF; Lesheski LE; Gogliotti RD; Sesnie JC; Solomon M; Mich TF
    J Med Chem; 1991 Feb; 34(2):656-63. PubMed ID: 1995890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of quinolones against mycobacteria.
    Jacobs MR
    Drugs; 1995; 49 Suppl 2():67-75. PubMed ID: 8549419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
    Vacher S; Pellegrin JL; Leblanc F; Fourche J; Maugein J
    J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antimycobacterial activity of a new quinolone, NM394].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses and biological activities of new N1-aryl substituted quinolone antibacterials.
    Jürgens J; Schedletzky H; Heisig P; Seydel JK; Wiedemann B; Holzgrabe U
    Arch Pharm (Weinheim); 1996 Apr; 329(4):179-90. PubMed ID: 8669982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
    Kawahara S; Tada A; Nagare H
    Kekkaku; 2001 Apr; 76(4):357-62. PubMed ID: 11398326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of quinolones against mycobacteria.
    Jacobs MR
    Drugs; 1999; 58 Suppl 2():19-22. PubMed ID: 10553700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple, inexpensive apparatus for performance of preparative scale solution phase multiple parallel synthesis of drug analogs. II. Biological evaluation of a retrospective library of quinolone antiinfective agents.
    Frank KE; Devasthale PV; Gentry EJ; Ravikumar VT; Keschavarz-Shokri A; Mitscher LA; Nilius A; Shen LL; Shawar R; Baker WR
    Comb Chem High Throughput Screen; 1998 Jun; 1(2):89-99. PubMed ID: 10500768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro antibacterial activity of some N-(5-aryl-1,3,4-thiadiazole-2-yl)piperazinyl quinolone derivatives.
    Foroumadi A; Soltani F; Moshafi MH; Ashraf-Askari R
    Farmaco; 2003 Oct; 58(10):1023-8. PubMed ID: 14505733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorocyclopropyl quinolones. 1. Synthesis and structure-activity relationships of 1-(2-fluorocyclopropyl)-3-pyridonecarboxylic acid antibacterial agents.
    Atarashi S; Imamura M; Kimura Y; Yoshida A; Hayakawa I
    J Med Chem; 1993 Oct; 36(22):3444-8. PubMed ID: 8230135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
    Dailloux M; Petitpain N; Henry C; Weber M
    Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in-vitro activity of sparfloxacin and eight other antimicrobial agents against clinical isolates of non-tuberculous mycobacteria.
    Sánchez-Carrillo C; Cotarelo M; Cercenado E; Vicente T; Blázquez R; Bouza E
    J Antimicrob Chemother; 1996 Jan; 37(1):151-4. PubMed ID: 8647757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimycobacterial activities of a new quinolone, sparfloxacin].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Oct; 66(10):643-9. PubMed ID: 1660089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antibacterial activity of some novel N-substituted piperazinyl-quinolones.
    Foroumadi A; Davood A; Mirzaei M; Emami S; Moshafi MH
    Boll Chim Farm; 2001; 140(6):411-6. PubMed ID: 11822230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of moxifloxacin against mycobacteria.
    Gillespie SH; Billington O
    J Antimicrob Chemother; 1999 Sep; 44(3):393-5. PubMed ID: 10511409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.